 Nathaniel Schaffer
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hip Fractures | 5 | 2025 | 87 | 2.010 |
Why?
| | Fracture Fixation, Intramedullary | 5 | 2025 | 60 | 1.950 |
Why?
| | Acetabulum | 2 | 2026 | 116 | 0.980 |
Why?
| | Fractures, Bone | 3 | 2026 | 428 | 0.870 |
Why?
| | Sciatic Neuropathy | 1 | 2024 | 30 | 0.840 |
Why?
| | Femur Head | 1 | 2024 | 38 | 0.820 |
Why?
| | Iatrogenic Disease | 1 | 2024 | 74 | 0.800 |
Why?
| | Bone Nails | 4 | 2025 | 61 | 0.780 |
Why?
| | Orthopedic Surgeons | 1 | 2023 | 30 | 0.740 |
Why?
| | Football | 1 | 2023 | 89 | 0.700 |
Why?
| | Ankle Fractures | 1 | 2020 | 20 | 0.630 |
Why?
| | Orthopedics | 1 | 2023 | 173 | 0.630 |
Why?
| | Tibial Fractures | 1 | 2020 | 73 | 0.600 |
Why?
| | Anticoagulants | 1 | 2023 | 748 | 0.530 |
Why?
| | Femoral Fractures | 2 | 2025 | 84 | 0.420 |
Why?
| | Bone Screws | 2 | 2026 | 115 | 0.390 |
Why?
| | Fracture Fixation, Internal | 2 | 2026 | 214 | 0.380 |
Why?
| | Bone Plates | 2 | 2025 | 81 | 0.360 |
Why?
| | Internship and Residency | 1 | 2023 | 1267 | 0.360 |
Why?
| | Spinal Fusion | 2 | 2021 | 262 | 0.260 |
Why?
| | Radiography | 3 | 2025 | 852 | 0.250 |
Why?
| | Retrospective Studies | 9 | 2025 | 17291 | 0.230 |
Why?
| | Hernia, Ventral | 2 | 2015 | 24 | 0.230 |
Why?
| | Herniorrhaphy | 2 | 2015 | 76 | 0.220 |
Why?
| | Sciatic Nerve | 1 | 2024 | 62 | 0.210 |
Why?
| | Patient Positioning | 1 | 2024 | 70 | 0.200 |
Why?
| | Blood Loss, Surgical | 1 | 2023 | 113 | 0.190 |
Why?
| | Compartment Syndromes | 1 | 2023 | 36 | 0.180 |
Why?
| | Warfarin | 1 | 2023 | 179 | 0.180 |
Why?
| | Humans | 18 | 2026 | 145475 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2023 | 172 | 0.160 |
Why?
| | Aspirin | 1 | 2023 | 406 | 0.150 |
Why?
| | Prostheses and Implants | 1 | 2020 | 137 | 0.150 |
Why?
| | Aged | 7 | 2025 | 26153 | 0.150 |
Why?
| | Deglutition Disorders | 1 | 2021 | 154 | 0.150 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2023 | 499 | 0.150 |
Why?
| | Tibia | 1 | 2020 | 176 | 0.140 |
Why?
| | Epigastric Arteries | 1 | 2018 | 33 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 484 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2025 | 11772 | 0.130 |
Why?
| | Hemorrhage | 1 | 2023 | 822 | 0.130 |
Why?
| | Dissection | 1 | 2018 | 57 | 0.130 |
Why?
| | Perforator Flap | 1 | 2018 | 35 | 0.130 |
Why?
| | Prevalence | 1 | 2024 | 2865 | 0.130 |
Why?
| | Antinematodal Agents | 1 | 2017 | 7 | 0.130 |
Why?
| | Nematoda | 1 | 2017 | 12 | 0.130 |
Why?
| | Helminth Proteins | 1 | 2017 | 24 | 0.130 |
Why?
| | Cohort Studies | 3 | 2023 | 6013 | 0.120 |
Why?
| | Abdominal Wall | 1 | 2015 | 28 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 207 | 0.110 |
Why?
| | Mammaplasty | 1 | 2018 | 142 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 919 | 0.110 |
Why?
| | Surgical Mesh | 1 | 2015 | 50 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2930 | 0.110 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2019 | 374 | 0.100 |
Why?
| | Postoperative Care | 1 | 2015 | 286 | 0.100 |
Why?
| | Drug Delivery Systems | 1 | 2017 | 381 | 0.100 |
Why?
| | Laparoscopy | 1 | 2018 | 481 | 0.100 |
Why?
| | Wound Healing | 1 | 2015 | 355 | 0.090 |
Why?
| | Postoperative Complications | 2 | 2025 | 2970 | 0.090 |
Why?
| | Reoperation | 2 | 2025 | 633 | 0.090 |
Why?
| | Physical Therapy Modalities | 1 | 2015 | 336 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 1149 | 0.080 |
Why?
| | Middle Aged | 4 | 2025 | 36215 | 0.070 |
Why?
| | Mixed Function Oxygenases | 1 | 2007 | 43 | 0.070 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2007 | 161 | 0.060 |
Why?
| | Fluoroscopy | 1 | 2026 | 180 | 0.060 |
Why?
| | Female | 6 | 2025 | 78845 | 0.060 |
Why?
| | Adult | 3 | 2025 | 40777 | 0.060 |
Why?
| | Male | 5 | 2025 | 72843 | 0.060 |
Why?
| | Open Fracture Reduction | 1 | 2025 | 30 | 0.050 |
Why?
| | Fracture Healing | 1 | 2025 | 91 | 0.050 |
Why?
| | Fatty Acids | 1 | 2007 | 457 | 0.050 |
Why?
| | Trauma Centers | 1 | 2025 | 466 | 0.040 |
Why?
| | Recurrence | 2 | 2015 | 1138 | 0.040 |
Why?
| | Publication Bias | 1 | 2021 | 18 | 0.040 |
Why?
| | Pseudarthrosis | 1 | 2021 | 14 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2021 | 197 | 0.040 |
Why?
| | Bacterial Proteins | 1 | 2007 | 967 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 477 | 0.040 |
Why?
| | Osseointegration | 1 | 2020 | 59 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2021 | 330 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 101 | 0.040 |
Why?
| | Michigan | 1 | 2019 | 134 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2020 | 168 | 0.040 |
Why?
| | Perioperative Care | 1 | 2021 | 231 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8333 | 0.030 |
Why?
| | Odds Ratio | 1 | 2021 | 1082 | 0.030 |
Why?
| | Comorbidity | 1 | 2023 | 1661 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 329 | 0.030 |
Why?
| | Nematode Infections | 1 | 2017 | 5 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2015 | 5423 | 0.030 |
Why?
| | Skin, Artificial | 1 | 2015 | 3 | 0.030 |
Why?
| | Flank Pain | 1 | 2015 | 9 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 2015 | 22 | 0.030 |
Why?
| | Tensile Strength | 1 | 2015 | 98 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1747 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2923 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2018 | 1111 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 740 | 0.020 |
Why?
| | Recovery of Function | 1 | 2015 | 716 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1371 | 0.020 |
Why?
| | Palmitic Acids | 1 | 2007 | 10 | 0.020 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 2007 | 10 | 0.020 |
Why?
| | Crystallization | 1 | 2007 | 136 | 0.020 |
Why?
| | Leucine | 1 | 2007 | 116 | 0.020 |
Why?
| | Methionine | 1 | 2007 | 161 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 387 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2007 | 486 | 0.010 |
Why?
| | Risk Assessment | 1 | 2015 | 3747 | 0.010 |
Why?
| | Binding Sites | 1 | 2007 | 1310 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1598 | 0.010 |
Why?
| | Animals | 1 | 2017 | 38030 | 0.010 |
Why?
|
|
Schaffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|